Business August 20, 2020
Johnson & Johnson to acquire Momenta Pharmaceuticals for 6.5B
Johnson & Johnson (NYSE: JNJ) announced its decision to acquire Momenta Pharmaceuticals (NASDA: MNTA) for $6.5 billion in an all-cash…
Business August 20, 2020
Johnson & Johnson (NYSE: JNJ) announced its decision to acquire Momenta Pharmaceuticals (NASDA: MNTA) for $6.5 billion in an all-cash…
By Marivic Cabural Summers
Business February 3, 2020
California defeated Johnson & Johnson in a legal battle involving the company’s pelvic mesh products for women. A Superior Court…
By Marivic Cabural Summers
Business October 10, 2019
A jury in the Philadelphia Court of Common Pleas ordered Johnson & Johnson to pay $8 billion in punitive damages…
By Marivic Cabural Summers
Investigates October 2, 2019
Johnson & Johnson reached a settlement agreement with Ohio counties that filed lawsuit in connection with its role in creating…
By Catherine Davis
Business August 27, 2019
A judge in Oklahoma ruled against Johnson & Johnson (NYSE:JNJ) in the state’s lawsuit alleging that its Janssen Pharmaceutical Companies…
By Marivic Cabural Summers
Business May 31, 2019
A jury in the New York State Supreme Court ordered Johnson & Johnson to pay $300 million to a woman…
By Marivic Cabural Summers
Business March 14, 2019
A California jury ordered Johnson & Johnson to pay $29 million to a woman who claimed that the talc in…
By Marivic Cabural Summers
Business February 21, 2019
Johnson & Johnson (NYSE:JNJ) received preliminary inquiries and subpoenas requesting for documents related to the safety of its baby powder…
By Marivic Cabural Summers
America January 22, 2019
Johnson & Johnson and its subsidiary Depuy agreed to pay $120 million to settle a multistate complaint involving its hip…
By Marivic Cabural Summers
Brand Stories December 17, 2018
Johnson & Johnson (NYSE:JNJ) strongly defended its Baby Powder against a report claiming that the company knew for decades that…
By Marivic Cabural Summers